Healthcare -
Medical - Diagnostics & Research - NASDAQ - US
$ 36.66
-1.74 %
$ 4.53 B
Market Cap
-8.61
P/E
Price Target
Average
2.56%
Revenue Forecast
Estimate
36.49%
EBIT
Estimate
--26.70%
Net Income
Estimate
15.94%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Guardant Health, Inc.
Wall Street analysts predict an average 1-year price target for GH of $37.6 , with forecasts ranging from
a
low of
$28 to a high of $50 .
GH Lowest Price Target
Wall Street Target
28 USD
-23.62%
GH Average Price Target
Wall Street Target
37.6 USD
2.56%
GH Highest Price Target
Wall Street Target
50 USD
36.39%
REVENUE FORECAST
Revenue Forecast Chart GH
EBIT FORECAST
EBIT Forecast Chart GH
NET INCOME FORECAST
Net Income Chart GH